GABELLI & Co INVESTMENT ADVISERS INC. Takes Position in Select Medical Holdings Corporation $SEM

GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in shares of Select Medical Holdings Corporation (NYSE:SEMFree Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 140,650 shares of the health services provider’s stock, valued at approximately $2,291,000. GABELLI & Co INVESTMENT ADVISERS INC. owned approximately 0.11% of Select Medical at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in SEM. Gamco Investors INC. ET AL acquired a new position in shares of Select Medical during the first quarter worth about $358,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Select Medical by 43.6% in the first quarter. Arrowstreet Capital Limited Partnership now owns 528,194 shares of the health services provider’s stock valued at $8,604,000 after buying an additional 160,278 shares in the last quarter. Caxton Associates LLP grew its stake in shares of Select Medical by 1,868.6% in the first quarter. Caxton Associates LLP now owns 349,564 shares of the health services provider’s stock valued at $5,694,000 after buying an additional 331,807 shares in the last quarter. Capula Management Ltd purchased a new stake in shares of Select Medical during the 1st quarter valued at about $3,369,000. Finally, Dimensional Fund Advisors LP lifted its position in Select Medical by 3.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,536,331 shares of the health services provider’s stock worth $90,188,000 after acquiring an additional 202,736 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Price Performance

Shares of NYSE:SEM opened at $16.51 on Friday. The firm has a market cap of $2.05 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 0.95 and a beta of 1.01. The company has a fifty day simple moving average of $16.54 and a 200 day simple moving average of $16.14. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $16.99.

Select Medical (NYSE:SEMGet Free Report) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The company’s revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, equities research analysts anticipate that Select Medical Holdings Corporation will post 1.26 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, May 28th. Investors of record on Thursday, May 14th were paid a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s dividend payout ratio (DPR) is 23.58%.

Wall Street Analyst Weigh In

Several analysts have issued reports on SEM shares. Zacks Research raised shares of Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Weiss Ratings raised shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Finally, Mizuho reaffirmed a “neutral” rating and set a $16.50 price target (down from $17.00) on shares of Select Medical in a report on Tuesday, May 12th. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Select Medical has an average rating of “Hold” and an average target price of $15.50.

Read Our Latest Research Report on SEM

Select Medical Company Profile

(Free Report)

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.

Featured Stories

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.